Recessive VARS2 mutation underlies a novel syndrome with epilepsy, mental retardation, short stature, growth hormone deficiency, and hypogonadism

Abstract
Most mitochondrial and cytoplasmic aminoacyl-tRNA synthetases (aaRSs) are encoded by nuclear genes. Syndromic disorders resulting from mutation of aaRSs genes display significant phenotypic heterogeneity. We expand aaRSs-related phenotypes through characterization of the clinical and molecular basis of a novel autosomal-recessive syndrome manifesting severe mental retardation, ataxia, speech impairment, epilepsy, short stature, microcephaly, hypogonadism, and growth hormone deficiency.A G>A variant in exon 29 of VARS2 (c.3650G>A) (NM_006295) was identified in the index case. This homozygous variant was confirmed by Sanger sequencing and segregated with disease in the family studied. The c.3650G>A change results in alteration of arginine to histidine at residue 1217 (R1217H) of the mature protein and is predicted to be pathogenic.These findings contribute to a growing list of aaRSs disorders, broadens the spectrum of phenotypes attributable to VARS2 mutations, and provides new insight into genotype-phenotype correlations among the mitochondrial synthetase genes.

Citation
Alsemari A, Al-Younes B, Goljan E, Jaroudi D, BinHumaid F, et al. (2017) Recessive VARS2 mutation underlies a novel syndrome with epilepsy, mental retardation, short stature, growth hormone deficiency, and hypogonadism. Human Genomics 11. Available: http://dx.doi.org/10.1186/s40246-017-0124-4.

Acknowledgements
This work was funded through grants from King Faisal Specialist Hospital and Research Centre (RAC 2140029) and King Abdulaziz City for Science and Technology (KACST#13-MED2056-20).

Publisher
Springer Nature

Journal
Human Genomics

DOI
10.1186/s40246-017-0124-4

PubMed ID
29137650

Additional Links
http://link.springer.com/article/10.1186/s40246-017-0124-4

Permanent link to this record